Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Internal Medicine Specialist
MBBS, FCPS (Medicine), Fellowship In Endocrinology
Endocrinologist
MSc in Diabetes and Endocrine
Internal Medicine Specialist
M.B.B.S., M.C.P.S, M.D.
Consultant Physician
M.B.B.S., F.C.P.S. (Medicine)
Consultant Physician
M.B.B.S., F.C.P.S., Diploma in Diabetes
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Consultant Physician
M.B.B.S, F.C.P.S. (Medicine), Postgraduate Diploma in Diabetes (UK), MRCP (Endocrinology and Dibetes)
Diabetologist
MBBS, MCPS (Family Medicine), MSc. (Diabetes and Endocrinology), DDM (Dip. Diabetes)
Diabetologist
MBBS, MCPS (Family Medicine), MSc. (Diabetes and Endocrinology), DDM (Dip. Diabetes)
Internal Medicine Specialist
M.B.B.S., F.C.P.S. (Medicine)
General Physician
MBBS, MCPS (Family Medicine)
Family Physician
M.C.P.S, M.B.B.S., Masters of Health Administration
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures